MANNKIND CORP (MNKD) Fundamental Analysis & Valuation

NASDAQ:MNKD • US56400P7069

Current stock price

2.79 USD
+0.16 (+6.08%)
At close:
2.8099 USD
+0.02 (+0.71%)
After Hours:

This MNKD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MNKD Profitability Analysis

1.1 Basic Checks

  • In the past year MNKD was profitable.
  • MNKD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: MNKD reported negative net income in multiple years.
  • In multiple years MNKD reported negative operating cash flow during the last 5 years.
MNKD Yearly Net Income VS EBIT VS OCF VS FCFMNKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.85%, MNKD belongs to the top of the industry, outperforming 87.77% of the companies in the same industry.
  • MNKD's Return On Invested Capital of 7.96% is amongst the best of the industry. MNKD outperforms 92.04% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MNKD is significantly below the industry average of 28.06%.
Industry RankSector Rank
ROA 0.85%
ROE N/A
ROIC 7.96%
ROA(3y)1.74%
ROA(5y)-9.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.85%
ROIC(5y)N/A
MNKD Yearly ROA, ROE, ROICMNKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 100 -100 -150

1.3 Margins

  • With an excellent Profit Margin value of 1.92%, MNKD belongs to the best of the industry, outperforming 88.35% of the companies in the same industry.
  • MNKD's Operating Margin of 16.59% is amongst the best of the industry. MNKD outperforms 92.62% of its industry peers.
  • MNKD has a Gross Margin of 77.80%. This is amongst the best in the industry. MNKD outperforms 83.11% of its industry peers.
  • MNKD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.59%
PM (TTM) 1.92%
GM 77.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.37%
GM growth 5Y4.31%
MNKD Yearly Profit, Operating, Gross MarginsMNKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. MNKD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MNKD is creating some value.
  • Compared to 1 year ago, MNKD has more shares outstanding
  • Compared to 5 years ago, MNKD has more shares outstanding
  • The debt/assets ratio for MNKD is higher compared to a year ago.
MNKD Yearly Shares OutstandingMNKD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
MNKD Yearly Total Debt VS Total AssetsMNKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • MNKD has an Altman-Z score of -4.21. This is a bad value and indicates that MNKD is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -4.21, MNKD is doing worse than 60.19% of the companies in the same industry.
  • MNKD has a debt to FCF ratio of 44.51. This is a negative value and a sign of low solvency as MNKD would need 44.51 years to pay back of all of its debts.
  • MNKD has a Debt to FCF ratio of 44.51. This is amongst the best in the industry. MNKD outperforms 88.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.51
Altman-Z -4.21
ROIC/WACC0.9
WACC8.8%
MNKD Yearly LT Debt VS Equity VS FCFMNKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

2.3 Liquidity

  • A Current Ratio of 1.70 indicates that MNKD should not have too much problems paying its short term obligations.
  • MNKD has a Current ratio of 1.70. This is amonst the worse of the industry: MNKD underperforms 80.78% of its industry peers.
  • MNKD has a Quick Ratio of 1.50. This is a normal value and indicates that MNKD is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.50, MNKD is not doing good in the industry: 82.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.5
MNKD Yearly Current Assets VS Current LiabilitesMNKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MNKD Growth Analysis

3.1 Past

  • The earnings per share for MNKD have decreased strongly by -28.75% in the last year.
  • MNKD shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.23%.
  • MNKD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.91% yearly.
EPS 1Y (TTM)-28.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
Revenue 1Y (TTM)22.23%
Revenue growth 3Y51.78%
Revenue growth 5Y39.91%
Sales Q2Q%45.82%

3.2 Future

  • MNKD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.97% yearly.
  • MNKD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.04% yearly.
EPS Next Y-84.66%
EPS Next 2Y80.18%
EPS Next 3Y62.55%
EPS Next 5Y48.97%
Revenue Next Year36.86%
Revenue Next 2Y23.74%
Revenue Next 3Y16.07%
Revenue Next 5Y17.04%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MNKD Yearly Revenue VS EstimatesMNKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M
MNKD Yearly EPS VS EstimatesMNKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 0.5 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. MNKD Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 46.50, MNKD can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, MNKD is valued cheaper than 90.68% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.89. MNKD is valued rather expensively when compared to this.
  • MNKD is valuated quite expensively with a Price/Forward Earnings ratio of 319.17.
  • MNKD's Price/Forward Earnings ratio is rather cheap when compared to the industry. MNKD is cheaper than 88.16% of the companies in the same industry.
  • MNKD is valuated expensively when we compare the Price/Forward Earnings ratio to 21.97, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 46.5
Fwd PE 319.17
MNKD Price Earnings VS Forward Price EarningsMNKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

  • 93.59% of the companies in the same industry are more expensive than MNKD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, MNKD is valued cheaper than 92.23% of the companies in the same industry.
Industry RankSector Rank
P/FCF 62.94
EV/EBITDA 15.92
MNKD Per share dataMNKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

  • MNKD has a very decent profitability rating, which may justify a higher PE ratio.
  • MNKD's earnings are expected to grow with 62.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y80.18%
EPS Next 3Y62.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MNKD Dividend Analysis

5.1 Amount

  • No dividends for MNKD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MNKD Fundamentals: All Metrics, Ratios and Statistics

MANNKIND CORP

NASDAQ:MNKD (4/28/2026, 5:30:32 PM)

After market: 2.8099 +0.02 (+0.71%)

2.79

+0.16 (+6.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)05-13
Inst Owners58.1%
Inst Owner Change0.06%
Ins Owners1.63%
Ins Owner Change2.5%
Market Cap861.55M
Revenue(TTM)348.97M
Net Income(TTM)6.70M
Analysts84
Price Target7.65 (174.19%)
Short Float %9.87%
Short Ratio4.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-116.48%
Min EPS beat(2)-439.47%
Max EPS beat(2)206.52%
EPS beat(4)1
Avg EPS beat(4)-85.96%
Min EPS beat(4)-439.47%
Max EPS beat(4)206.52%
EPS beat(8)2
Avg EPS beat(8)-74.12%
EPS beat(12)5
Avg EPS beat(12)-38.6%
EPS beat(16)6
Avg EPS beat(16)-28.6%
Revenue beat(2)2
Avg Revenue beat(2)6.39%
Min Revenue beat(2)0.33%
Max Revenue beat(2)12.45%
Revenue beat(4)3
Avg Revenue beat(4)2.28%
Min Revenue beat(4)-4.55%
Max Revenue beat(4)12.45%
Revenue beat(8)6
Avg Revenue beat(8)2.33%
Revenue beat(12)9
Avg Revenue beat(12)3.51%
Revenue beat(16)12
Avg Revenue beat(16)6.12%
PT rev (1m)-21.97%
PT rev (3m)-21.97%
EPS NQ rev (1m)12.59%
EPS NQ rev (3m)-137.5%
EPS NY rev (1m)-83.59%
EPS NY rev (3m)-92.86%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)5.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)9.36%
Valuation
Industry RankSector Rank
PE 46.5
Fwd PE 319.17
P/S 2.47
P/FCF 62.94
P/OCF 47.2
P/B N/A
P/tB N/A
EV/EBITDA 15.92
EPS(TTM)0.06
EY2.15%
EPS(NY)0.01
Fwd EY0.31%
FCF(TTM)0.04
FCFY1.59%
OCF(TTM)0.06
OCFY2.12%
SpS1.13
BVpS-0.17
TBVpS-1.44
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA 0.85%
ROE N/A
ROCE 9.32%
ROIC 7.96%
ROICexc 10.76%
ROICexgc 55.79%
OM 16.59%
PM (TTM) 1.92%
GM 77.8%
FCFM 3.92%
ROA(3y)1.74%
ROA(5y)-9.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.85%
ROIC(5y)N/A
ROICexc(3y)28.62%
ROICexc(5y)N/A
ROICexgc(3y)44.91%
ROICexgc(5y)N/A
ROCE(3y)12.18%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.37%
GM growth 5Y4.31%
F-Score5
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 44.51
Debt/EBITDA 8.33
Cap/Depr 37.17%
Cap/Sales 1.31%
Interest Coverage 3.93
Cash Conversion 26.02%
Profit Quality 204.41%
Current Ratio 1.7
Quick Ratio 1.5
Altman-Z -4.21
F-Score5
WACC8.8%
ROIC/WACC0.9
Cap/Depr(3y)368.18%
Cap/Depr(5y)300.07%
Cap/Sales(3y)8.68%
Cap/Sales(5y)9.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-266.67%
EPS Next Y-84.66%
EPS Next 2Y80.18%
EPS Next 3Y62.55%
EPS Next 5Y48.97%
Revenue 1Y (TTM)22.23%
Revenue growth 3Y51.78%
Revenue growth 5Y39.91%
Sales Q2Q%45.82%
Revenue Next Year36.86%
Revenue Next 2Y23.74%
Revenue Next 3Y16.07%
Revenue Next 5Y17.04%
EBIT growth 1Y-18.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-58.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-57.06%
OCF growth 3YN/A
OCF growth 5YN/A

MANNKIND CORP / MNKD Fundamental Analysis FAQ

What is the fundamental rating for MNKD stock?

ChartMill assigns a fundamental rating of 5 / 10 to MNKD.


Can you provide the valuation status for MANNKIND CORP?

ChartMill assigns a valuation rating of 5 / 10 to MANNKIND CORP (MNKD). This can be considered as Fairly Valued.


What is the profitability of MNKD stock?

MANNKIND CORP (MNKD) has a profitability rating of 6 / 10.


How financially healthy is MANNKIND CORP?

The financial health rating of MANNKIND CORP (MNKD) is 3 / 10.


Can you provide the expected EPS growth for MNKD stock?

The Earnings per Share (EPS) of MANNKIND CORP (MNKD) is expected to decline by -84.66% in the next year.